ICL expands portfolio with Bartek Ingredients acquisition
ICL Group is acquiring Bartek Ingredients in a two-phase deal, starting with US$90 million for 50% stake in Q1 2026.
ISRAEL/CANADA – ICL Group Ltd, a global specialty minerals and ingredients powerhouse, has entered a definitive agreement to acquire Bartek Ingredients Inc., a leading producer of food-grade malic and fumaric acids, in a two-phase transaction announced December 18, 2025.
The initial phase, expected to close in Q1 2026 pending regulatory approvals, involves a US$90 million cash investment for approximately 50% ownership, with full control targeted upon achieving business and integration milestones.
Bartek’s US$65 million annual revenue and new production facility set for 2026 completion, position ICL to capture growth in the US$45 billion functional food ingredients market through enhanced flavor, shelf-life, and stability solutions for food, beverage, bakery, and confectionery applications.
Headquartered in Tel Aviv with major operations in St. Louis, ICL leverages this bolt-on to deepen its specialty food solutions platform, complementing phosphate salts and plant-based texturizers.
Bartek, based in Windsor, Ontario, Canada, operates North America’s only fully integrated malic and fumaric acid facilities, serving 40+ countries with pH control, souring agents, and preservatives essential for sour candies, beverages, and low-acid bakery fillings.
The acquisition accelerates ICL’s non-organic growth strategy in high-margin segments, building on recent expansions like plant protein isolates amid clean-label demands.
ICL President and CEO Elad Aharonson highlighted strategic alignment: “Bartek’s market leadership strengthens our global food presence, enabling expansion into adjacent ingredient categories through combined technical expertise and R&D.”
Bartek CEO Andrew Ross echoed synergies: “ICL’s scale unlocks our potential in the booming functional ingredients space, delivering enhanced value via expanded capacity and distribution.“
The new Ontario plant promises significant volume uplift, supporting applications from gummy bears requiring precise tartness to bakery emulsions needing pH stability.
This move responds to CPG trends favoring natural acidulants over synthetic alternatives, with malic acid consumption rising 8% annually per market data.
ICL’s global footprint facilitates Bartek’s penetration into Asia-Pacific and Europe, where regulatory shifts favor bio-based preservatives.
Financially disciplined at 7-8x EBITDA, the deal maintains ICL’s investment-grade balance sheet while targeting double-digit EPS accretion post-integration.
For industrial bakers, Bartek’s acids enable reduced-sugar formulations and extended freshness without benzoates, aligning with EU clean-label mandates.
The partnership boosts ICL against rivals like Jungbunzlauer and Tate & Lyle, enhancing formulation support through combined application labs.
Analysts project 15% revenue growth for ICL’s food solutions division by 2028, driven by capacity expansion and cross-selling.
ICL’s acquisition underscores Israel’s innovation-driven M&A resurgence, transforming commodity chemicals into premium nutrition enablers.
As functional foods surge, projected 7% CAGR, Bartek integration cements ICL’s leadership, fusing Israeli strategy with Canadian manufacturing prowess for sustained dominance in a flavor-forward future.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
